vimarsana.com

Latest Breaking News On - Swedish neuroscience institute - Page 2 : vimarsana.com

Spinal Resources Inc. Unveils Groundbreaking Spine Platform for Improved Patient Care

Fort Lauderdale, FL (PRWEB) April 04, 2023 Spinal Resources Inc. (SRI), a leading innovator in spinal technology, has announced the FDA-approval of its

Florida
United-states
Sweden
Swedish
Roland-kent
Johns-hopkins
Hamid-hassanzadeh
Robert-hart
Bernardm-bedor
Axis-spine-center
Solutions-based-spine-platform
Resources-inc

ACTRIMS 2023: Most patients on Briumvi show no MS activity after 6 months | Briumvi led to no MS activity in 80% of patients in ULTIMATE trials

More than 80% of MS patients on Briumvi in the ULTIMATE trials had no signs of disease activity after the first six months, data show.

Colorado
United-states
Sweden
California
San-diego
Washington
Swedish
Enrique-alvarez
Peiqing-qian
Swedish-neuroscience-institute
University-of-colorado
Americas-committee-for-treatment

Dr. Robert E. Ayer Has Been Reviewed And Approved By GA Top Docs For 2022

Scotch Plains, NJ (PRWEB) October 21, 2022 Robert Ayer, MD, FAANS is a board-certified neurosurgeon and partner at Polaris Spine and Neurosurgery Center,

Loma-linda
California
United-states
Georgia
Atlanta
Washington
Sweden
Loma-linda-university-medical-center
Swedish
Roberte-ayer
Robert-ayer
Instagram

Pain and Anxiety Should Be Dealt With Soon After Multiple Sclerosis Diagnosis

In the first year after a diagnosis of multiple sclerosis, 60% of patients experience fatigue, 50% experience pain, 47% have symptoms of depression, and 39% report increased anxiety. Researchers say urgent, non-pharmaceutical therapies should be provided for newly diagnosed MS patients to help reduce both pain and mental health symptoms.

Sweden
Swedish
Kevin-alschuler
Ivan-molton
Kevinn-alschuler
Thomasr-valentine
University-of-washington
Swedish-neuroscience-institute-ms-center
Uw-medicine-multiple-sclerosis-center
National-multiple-sclerosis-society
Ms-research
Multiple-sclerosis-journal

Non-pharmaceutical help should be offered for pain, fatigue, anxiety at the time of MS diagnosis

Two recently published studies by UW Medicine researchers indicate that clinicians should offer non-pharmaceutical help for pain, fatigue, depression, or anxiety at the time of diagnosis for patients with multiple sclerosis, rather than wait.

Sweden
Swedish
Kevin-alschuler
Ivan-molton
Emily-henderson
Swedish-neuroscience-institute-ms-center
Uw-medicine-multiple-sclerosis-center
National-multiple-sclerosis-society
Ms-research
Multiple-sclerosis-journal
Multiple-sclerosis-center
Swedish-neuroscience-institute

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.